Matthew Maenner is surveillance team lead for the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention.
Matthew Maenner
Surveillance team lead
National Center on Birth Defects and Developmental Disabilities
From this contributor
Q&A with Matthew Maenner: Estimating autism prevalence quickly
A new method to track autism prevalence in 11 U.S. states is twice as fast as the old approach — and yields similar results.
Q&A with Matthew Maenner: Estimating autism prevalence quickly
By
Peter Hess
13 July 2021 | 6 min read
Explore more from The Transmitter
By
Keerthana Iyer, Arish Mudra Rakshasa-Loots, Ana Silva, Violetta Zujovic
21 July 2026
5 min read
Redefining underrepresentation in global neuroscience
Shifting the focus of equity initiatives from identity categories to structural barriers can reveal overlooked challenges and increase support and participation worldwide.
Redefining underrepresentation in global neuroscience
Shifting the focus of equity initiatives from identity categories to structural barriers can reveal overlooked challenges and increase support and participation worldwide.
By
Keerthana Iyer, Arish Mudra Rakshasa-Loots, Ana Silva, Violetta Zujovic
21 July 2026 | 5 min read
Separate neuronal pathways mediate social, attentional behaviors
Here is a roundup of autism-related news and research spotted around the web for the week of 20 July.
Separate neuronal pathways mediate social, attentional behaviors
Here is a roundup of autism-related news and research spotted around the web for the week of 20 July.
By
Jill Adams
21 July 2026 | 2 min read
In memoriam: Susumu Tonegawa, ‘intellectual giant’
He won the Nobel Prize for his work on immunology and then went on to define the field of learning and memory.
In memoriam: Susumu Tonegawa, ‘intellectual giant’
He won the Nobel Prize for his work on immunology and then went on to define the field of learning and memory.
By
Claudia López Lloreda
17 July 2026 | 6 min read